Based on ratings from 7 stock analysts, the Sabra Health Care REIT Inc stock price is expected to increase by 18.76% in 12 months. This is calculated by using the average 12-month stock price forecast for Sabra Health Care REIT Inc. The lowest target is $14.00 and the highest is $21.00. Please note analyst price targets are not guaranteed and could be missed completely.
Sabra Health Care REIT Inc has a total of 7 Wall St Analyst ratings. There are 4 buy ratings, 3 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Sabra Health Care REIT Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
connor siversky Wells Fargo | Hold | $14.0 | maintained | Jan 30, 2024 |
dave rodgers Robert W. Baird | Hold | $15.0 | maintained | Dec 8, 2023 |
nicholas yulico Scotiabank | Hold | $14.0 | maintained | Nov 17, 2023 |
aaron hecht JMP Securities | Hold | None | maintained | Nov 17, 2023 |
juan c. sanabria BMO Capital | Hold | $16.0 | downgraded | Oct 17, 2023 |
wes golladay Robert W. Baird | Hold | $13.0 | maintained | Aug 17, 2023 |
steven valiquette Barclays | Hold | $13.0 | rated | Aug 10, 2023 |
tao qiu Berenberg Bank | Hold | $13.0 | initiatedcoverage | Jul 27, 2023 |
nicholas joseph Citigroup | Hold | $11.0 | maintained | May 16, 2023 |
jonathan petersen Jefferies | Hold | $14.0 | downgraded | Jun 30, 2022 |
daniel bernstein Capital One Financial | Hold | $15.5 | initiatedcoverage | Jun 3, 2022 |
jordan sadler KeyBanc | Hold | None | initiatedcoverage | Feb 18, 2022 |
haendel st. juste Mizuho Securities | Hold | $18.0 | initiatedcoverage | Jul 14, 2021 |
eric fleming Truist Financial | Hold | None | downgraded | Dec 18, 2018 |
jonathan hughes Raymond James | Hold | $24.0 | downgraded | Nov 16, 2018 |
todd stender Wells Fargo | Hold | $19.0 | reiterated | Mar 20, 2018 |
chad vanacore Stifel Nicolaus | Hold | $21.0 | reiterated | Feb 22, 2018 |
paul morgan Canaccord Genuity | Hold | $26.0 | maintained | Jul 25, 2017 |
aravinda galappatthige Canaccord Genuity | Hold | $0.3 | downgraded | Apr 3, 2016 |
robert mains Stifel Nicolaus | Hold | None | downgraded | Nov 16, 2015 |
In 2023, SBRA generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SBRA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11